Skip to main content

Eden Research to use Polish approval for Mevalone as springboard into central Europe

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Eden Research PLC (AIM:EDEN, OTCQB:EDNSF) CEO Sean Smith speaks to Proactive after announcing that the company's flagship bio-fungicide Mevalone has been approved for use by Polish regulators.

Smith says that the authorisation in Poland is just the beginning of a cascading process that will continue into adjacent European Union member states as well as the United Kingdom.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.11
-1.55 (-0.66%)
AAPL  333.02
+11.36 (3.53%)
AMD  521.95
-17.74 (-3.29%)
BAC  62.05
+0.77 (1.26%)
GOOG  319.09
+0.75 (0.24%)
META  595.19
-10.91 (-1.80%)
MSFT  381.70
+0.12 (0.03%)
NVDA  206.84
-1.92 (-0.92%)
ORCL  114.99
-5.05 (-4.21%)
TSLA  313.03
-6.66 (-2.08%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.